PMDA / 日本 (Japanese Pharmaceuticals, 2023-07: Japan's approved label for Stromectol 3 mg tablets, indicating intestinal strongyloidiasis and scabies only.
承認番号 21400AMY00237000
1
PMDA / 日本 (Japanese Pharmaceuticals, 2023-07: Japan's approved label for Stromectol 3 mg tablets, indicating intestinal strongyloidiasis and scabies only. C6 Japan. Original title: ストロメクトール錠3mg 添付文書 (English: Stromectol tablets 3 mg, package insert). Record fields transcribed from the PDF text layer: approval number 21400AMY00237000, sales start 2002年12月 (December 2002), revision 2023年7月改訂(第1版). Section 4 効能又は効果 lists exactly two indications: ○腸管糞線虫症 (intestinal strongyloidiasis) and ○疥癬 (scabies) – onchocerciasis is NOT an approved indication in Japan. Translation of the indication lines: 'Intestinal strongyloidiasis / Scabies'. Because the quote is a bare record field from a two-column Japanese page (the PDF's columns interleave), confidence is MEDIUM; the excerpt was checked against the default pdftotext extraction. Study type: regulatory record.
